Finance

Lists
BICO:STO
BICO Group AB
SEK 16.30
0.00%
(0.00) 1D
Nov 18, 5:29:57 PM GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for BICO...
Mkt. cap
1.13B
Avg. vol.
561.14K
Volume
0.00
52-wk high
SEK 25.40
52-wk low
SEK 12.94
EPS
-SEK 6.35
Shares outstanding
69.07M
No. of employees
512
Mkt. cap
1.13B
Avg. vol.
561.14K
Volume
0.00
52-wk high
SEK 25.40
52-wk low
SEK 12.94
EPS
-SEK 6.35
Shares outstanding
69.07M
No. of employees
512
News stories
From web sources and news partners
Profile
Bico Group is a Swedish bioconvergence company that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting. Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet. The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
About BICO Group AB
CEO-
Employees512
FoundedJan 27, 2016
Headquarters-
SectorHealth Care
Industry-
Websitebico.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
451.30M
329.90M
336.10M
465.20M
Cost of goods sold
215.90M
151.30M
136.90M
161.50M
Cost of revenue
215.90M
151.30M
136.90M
161.50M
Research and development expenses
48.80M
49.30M
56.90M
42.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
204.30M
224.80M
179.70M
196.50M
Operating expense
249.50M
269.80M
229.40M
241.40M
Total operating expenses
465.40M
421.10M
366.30M
402.90M
Operating income
-14.10M
-91.20M
-30.20M
62.30M
Other non operating income
-8.40M
-
-100.00K
25.40M
EBT including unusual items
-57.00M
-127.50M
-34.90M
-225.60M
EBT excluding unusual items
-73.30M
-105.30M
-23.60M
73.00M
Income tax expense
2.20M
3.80M
2.30M
-5.20M
Effective tax rate
-3.86%
-2.98%
-6.59%
2.30%
Other operating expenses
-3.60M
-4.30M
-7.20M
2.00M
Net income
-55.00M
-131.30M
-37.20M
-220.40M
Net profit margin
-12.19%
-39.80%
-11.07%
-47.38%
Earnings per share
-
-
-
-
Interest and investment income
212.00M
9.10M
20.30M
-
Interest expense
-11.90M
-23.20M
-13.60M
-14.70M
Net interest expenses
200.10M
-14.10M
6.70M
-14.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
48.40M
-20.10M
27.00M
405.80M
Gain or loss from assets sale
-480.30M
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps